HF 225: Relating to the right to try Act

What it does

This bill relates to Code chapter 144E, the right to try Act. Under current law, an “eligible patient” under the Code chapter is, in part, a person who has a terminal illness. Under the bill, an “eligible patient” is instead, in part, a person who has a life-threatening or severely debilitating illness. Under current law, the Code chapter applies to an “investigational drug, biological product, or device” meaning a drug, biological product, or device that has successfully completed phase I of a United States food and drug administration (FDA)-approved clinical trial but has not yet been approved for general use by the FDA and that remains under investigation in an FDA-approved clinical trial.

House subcommittee · named February 22, 2023

• Rep. Brooke Boden (R) · brooke.boden@legis.iowa.gov
• Rep. Eddie Andrews (R) · eddie.andrews@legis.iowa.gov
• Rep. Austin Baeth (D) · austin.baeth@legis.iowa.gov

Lobbying · 2 for, 0 against

For: Iowans for Tax Relief; The ALS Association

In plain words

1. February 7, 2023Filed in the House and sent to the Health and Human Services committee
2. February 22, 2023House subcommittee named: Boden, Andrews and Baeth
3. March 1, 2023Subcommittee recommended passing it